Amgen to repay term loan borrowings via senior note offering proceeds

By Tali Rackner

Norfolk, Va., Feb. 18 – Amgen Inc. plans to repay borrowings under its term loan credit agreement with the proceeds from two new senior note offerings, according to a 424B3 filing with the Securities and Exchange Commission.

Proceeds will also be used to repurchase shares of common stock pursuant to the company’s stock repurchase program and for general corporate purposes.

As of Dec. 31, there was $1,975,000,000 of term loans outstanding under the credit agreement.

The manufacturer and marketer of human therapeutics based upon advances in cellular and molecular biology is based in Thousand Oaks, Calif.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.